Study Finds Lower Risk for Hematologic Cancer in Woman After Bariatric Surgery

A recent study published in Lancet Healthy Longevity suggests that bariatric surgery, a weight loss procedure, is linked to a lower risk of blood cancer, particularly in women. The research, involving over 2,000 individuals who underwent surgery and a similar group who did not, revealed a significant reduction in the incidence and mortality of blood cancers among those who had bariatric surgery. Notably, the benefit was more pronounced in women, especially those with high blood sugar levels at the beginning of the study.

Dr. Magdalena Taube, one of the researchers, emphasized the connection between the surgery’s benefits and baseline blood glucose levels, stating, “The reduced risk of hematological cancer was much more pronounced if the women’s blood sugar levels were high at the beginning, which clearly shows that blood sugar is an important factor in cancer development.”

The study found that participants who had bariatric surgery experienced a 55% lower risk of lymphomas, a type of blood cancer. Interestingly, the positive effects of the surgery on reducing the incidence of hematologic cancer were observed in women but not in men.

Dr. Alexander Abkin, a bariatric surgeon in New Jersey, commented on the study, stating, “This research reinforces the growing evidence supporting the positive impact of bariatric surgery on reducing the risk of blood cancer, particularly in women. The significant reduction in hematologic cancer incidence and mortality among individuals who underwent bariatric surgery highlights the potential preventive benefits of weight loss surgery.”

“Intriguingly, the study suggests a noteworthy connection between the surgery’s effectiveness and baseline blood glucose levels, emphasizing the role of blood sugar in influencing cancer development. This finding underscores the broader impact that metabolic improvements from bariatric surgery may have on reducing the risk of various cancers,” added Dr. Abkin.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *